Company Monitoring Page for JNJ

latest headlines for company on cafepharma

This Week in Biotech
Motley Fool
Sun, 12/9/12 - 11:23 am
Tags:
JNJ, Chelsea Therapeutics, Anika, Geron, Zogenix
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Tags:
Alexza, BiogenIdec, Celsion, Celgene, Sanofi, JNJ, Threshold Pharmaceuticals
Johnson & Johnson files for approval to market Stelara for psoriatic arthritis in US and EU
Yahoo/AP
Thu, 12/6/12 - 11:51 am
Tags:
psoriatic arthritis, JNJ, Stelara
Do Oxtellar and Trokendi Make Supernus a Buy?
Motley Fool
Wed, 12/5/12 - 12:06 pm
Tags:
Oxtellar, Trokendi, Supernus Pharmaceuticals, JNJ, Novartis
Johnson & Johnson One-Ups Tuberculosis
Motley Fool
Sun, 12/2/12 - 12:05 pm
Tags:
JNJ, tuberculosis, bedaquiline
A Winning Long-Term Growth Pick
Motley Fool
Sat, 12/1/12 - 09:53 am
Tags:
JNJ
J&J Wins Reversal of $1.1 Million Levaquin Punitive Award
Bloomberg
Fri, 11/30/12 - 04:00 pm
Tags:
JNJ, Levaquin
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Fri, 11/30/12 - 12:18 pm
Tags:
NPS Pharmaceuticals, Medivation, JNJ, Celgene, Amarin
J&J CEO Gorsky elected chairman, replacing Weldon
Reuters
Fri, 11/30/12 - 09:41 am
Tags:
JNJ, Pharma CEOs, William Weldon, Alex Gorsky
J&J says won't enforce AIDS drug patent in Africa
Reuters
Thu, 11/29/12 - 11:04 am
Tags:
AIDS, JNJ, Africa, patents, Prezista
FDA advisory panel backs J&J TB drug
Reuters
Thu, 11/29/12 - 10:38 am
Tags:
JNJ, FDA, advisory panels, tuberculosis, bedaquiline
GSK and J&J lead rivals in drug access for poor
Reuters
Wed, 11/28/12 - 10:18 am
Tags:
JNJ, GSK
J&J preps case for quick FDA approval of new TB drug
Fierce Biotech
Mon, 11/26/12 - 12:21 pm
Tags:
JNJ, FDA, tuberculosis, bedaquiline
This Healthcare Giant Needs to Focus on Organic Growth
Motley Fool
Wed, 11/21/12 - 11:21 am
Tags:
JNJ
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thu, 11/15/12 - 11:13 am
Tags:
JNJ, Eli Lilly, Merck, clinical trials
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
Tags:
diabetes, JNJ, Merck, Bristol-Myers Squibb, AstraZeneca, SGLT2 inhibitor
Can You Profit From 4 Big Pharmas Making Headlines?
Motley Fool
Wed, 11/14/12 - 11:30 am
Tags:
Abbott Labs, JNJ, Merck, Pfizer
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
Tags:
prostate cancer, Medivation, Dendreon, Provenge, JNJ, Sanofi
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Tags:
Xtandi, Zytiga, prostate cancer, JNJ, Medivation, Astellas

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.